Study guide

14.1 Specimens, Major Pathogens, and Disease States

ASCP Microbiology Technologist M ASCP

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current M(ASCP) Exam Facts 1.2 CAT, Scoring, Retakes, and CMP 1.3 Eligibility Routes and Clinical Experience

2 Preanalytic: Collection and Transport

2.1 Patient Identification and Specimen Labeling 2.2 Specimen Collection, Sterile Technique, and Blood Cultures 2.3 Transport Devices, Atmosphere, Time, and Temperature

3 Preanalytic: Processing, Media, and Incubation

3.1 Prioritization, Rejection, and Specimen Preparation 3.2 Media Types, Components, and Selection 3.3 Inoculation, Incubation Conditions, and Slide Preparation

4 Preanalytic: Stains

4.1 Gram Stain: Procedure, Principle, and Interpretation 4.2 Acid-Fast and Modified Acid-Fast Stains 4.3 KOH, Calcofluor-White, Trichrome, Giemsa, and Acridine Orange

5 Bacteriology: Blood and Bone Marrow

5.1 Blood Culture Systems and Rapid Identification 5.2 Bloodstream Pathogens and Skin Flora Significance 5.3 Endocarditis, Bone Marrow Pathogens, and Pathogenicity

6 Bacteriology: CSF and Sterile Body Fluids

6.1 CSF Sources and Acute Meningitis Pathogens 6.2 Shunt Infections, CSF Correlates, Antigen and Molecular Methods 6.3 Sterile Body Fluids: Pathogens, Flora, and Molecular Methods

7 Bacteriology: Respiratory Tract

7.1 Lower Respiratory Specimens, CAP, and HAP Pathogens 7.2 Cystic Fibrosis Pathogens and Quantitative Reporting 7.3 Upper Respiratory: Pharyngitis, Otitis, Sinusitis, Antigen/Molecular

8 Bacteriology: Gastrointestinal Tract

8.1 Enteric Pathogens: Culture and Colony Morphology 8.2 Clostridioides difficile, Shiga Toxin, and Serotyping 8.3 Helicobacter pylori Detection and GI Pathogenicity

9 Bacteriology: Skin, Soft Tissue, and Bone

9.1 Skin, Soft Tissue, and Bone Pathogens 9.2 Bite Wounds and Zoonotic Infections 9.3 SST Pathogenicity and Virulence Mechanisms

10 Bacteriology: Genital Tract and Urine

10.1 Genital Flora and Vaginitis Pathogens 10.2 Neisseria gonorrhoeae, Chlamydia trachomatis, GBS, and Mycoplasma 10.3 Urinary Pathogens, Colony Counts, and Urinalysis Correlation

11 Bacteriology: Identification Methods

11.1 Colony Morphology and Rapid Presumptive Tests 11.2 Conventional Biochemicals and Commercial Kits 11.3 Automated Methods, MALDI-TOF MS, Molecular, and 16S Sequencing

12 Bacteriology: Antimicrobial Susceptibility and Resistance

12.1 Microbroth Dilution, Disk Diffusion, and Gradient Diffusion 12.2 Phenotypic Detection of Resistance 12.3 Antibiotic Classes, Intrinsic Resistance, and Genetic Markers

13 Bacteriology: Resistance Screening and Select Agents

13.1 MRSA/MSSA, VRE, ESBL/CRE Screening 13.2 BSL-3 Pathogens and Select-Agent Presumptive Identification 13.3 Laboratory Response Network and Select-Agent Pathogenicity

14 Mycobacteriology and Nocardia

14.1 Specimens, Major Pathogens, and Disease States 14.2 Acid-Fast Reaction, Colony Morphology, and Growth Characteristics 14.3 Identification Methods, Direct Molecular Detection, and TB Therapy

15 Virology

15.1 Respiratory, Vesicle, Meningitis, and GI Viruses 15.2 Hepatitis, HIV, and Immunocompromised-Host Viruses 15.3 Direct Detection Methods and HPV Cervical Screening

16 Parasitology

16.1 Blood, Tissue, and Brain Protozoa 16.2 Intestinal/Urogenital Protozoa and Helminths 16.3 Microscopy, Antigen/Molecular Detection, Insects and Arthropods

17 Mycology

17.1 Yeasts: Candida, Cryptococcus, and Malassezia 17.2 Dimorphic Fungi and Dermatophytes 17.3 Mucorales, Hyaline Molds, Pneumocystis, and Identification Methods

18 Serology

18.1 Immunoglobulin Response and Antigen-Antibody Methods 18.2 Viral Serodiagnosis: Hepatitis, EBV, HIV, CMV, Rubella, Measles 18.3 Treponema, Borrelia, and TB Infection Serodiagnosis

19 Laboratory Operations: Postanalytic Procedures and Quality

19.1 Documentation, Critical Values, Corrected Reports, and Public Health 19.2 Quality Control, Root-Cause Analysis, and POCT 19.3 Proficiency Testing, Competency, and Accreditation

20 Laboratory Operations: Safety, Mathematics, and Instrumentation

20.1 Biosafety, PPE, Bloodborne Pathogens, and SDS 20.2 Emergencies and Packaging/Transportation of Specimens 20.3 Laboratory Mathematics and Instrumentation

14.1 Specimens, Major Pathogens, and Disease States

Key Takeaways Explain This Topic AI

Lower-respiratory specimens (sputum, BAL) are digested and decontaminated for AFB culture; dedicated mycobacterial blood cultures diagnose disseminated MAC; soft-tissue biopsies for M. marinum, M. abscessus, and Nocardia need a 30 °C set when aquatic or extremity disease is suspected.

M. tuberculosis is transmitted person-to-person by airborne droplet nuclei (about 1–5 µm); propagating cultures is BSL-3 work because a grown isolate is a concentrated aerosol hazard.

MAC is environmental (water and soil), not contagious; disseminated MAC is a disease of advanced AIDS, while pulmonary MAC occurs in COPD, bronchiectasis, and cystic fibrosis.

M. kansasii causes TB-like cavitary pulmonary disease; the M. abscessus group is a rapid grower of CF lung and post-procedure skin infection; M. marinum is fish-tank granuloma incubated at 30 °C.

Nocardia is a partially acid-fast branching Gram-positive filament that causes pulmonary disease and brain abscess in immunocompromised hosts; M. gordonae is the tap-water scotochromogen contaminant, not a TB equivalent.

Last updated: August 2026

14.1 Specimens, Major Pathogens, and Disease States

Quick Answer: Plant digested sputum or BAL for pulmonary TB and NTM, a dedicated mycobacterial blood culture for disseminated MAC, and tissue or aspirate (with a 30 °C set) for M. marinum , M. abscessus , and Nocardia . M. tuberculosis spreads person-to-person by airborne droplet nuclei and is a BSL-3 culture organism. MAC is environmental and disseminates in advanced AIDS. M. kansasii mimics pulmonary TB. M. abscessus is a rapid grower of CF lung and skin. M. marinum is fish-tank granuloma. Nocardia is a partially acid-fast branching Gram-positive filament with pulmonary and brain disease in immunocompromised hosts. M. gordonae is the tap-water contaminant.

Domain III (Mycobacteriology, Virology, Parasitology, Mycology) is 20–30% of the M examination. Official outline III.A Mycobacteriology and Nocardia spp. (content guideline revised 2025-09-25 ) is the acid-fast half of that domain. This section is the clinical map: which specimen to plant, which organism is a pathogen versus a water organism, and how the patient acquired disease. Growth rate, pigment, and cords are 14.2. Sequencing, MALDI inactivation, direct NAAT, and RIPE/MDR/XDR concepts are 14.3. Less-common mycobacteria listed as SM-only on the outline ( M. leprae , M. haemophilum , M. scrofulaceum ) are not M-tested content —do not spend exam time on their special media or AST.

Specimen sources the outline names

A mycobacteriology workup is only as good as the specimen. The M outline groups sources around lower respiratory , blood , and soft tissue . They are not interchangeable, and they do not all go to 37 °C on the same media.

Source Typical material Why it is collected Bench implication

Lower respiratory Expectorated or induced sputum, BAL, bronchial wash Pulmonary TB and NTM lung disease Digest and decontaminate (NALC–NaOH); plant liquid plus solid media

Blood Mycobacterial blood-culture bottle or lysis-centrifugation Disseminated MAC in advanced AIDS; occasional TB bacteremia Do not treat a routine 5-day bacterial bottle as an AFB culture

Soft tissue Biopsy, aspirate, drainage (avoid dry swabs) M. marinum , M. abscessus group, cutaneous Nocardia Incubate a 30 °C set when aquatic or extremity lesions are in the history

First-morning sputum on three consecutive days remains the classic pulmonary TB collection because overnight secretions concentrate AFB. Induced sputum or BAL is used when the cough is dry. Gastric lavage appears in pediatric practice because young children swallow sputum; it is still a respiratory specimen conceptually. Do not use the NALC–NaOH digest as an excuse to skip a tissue grind: biopsies for Nocardia and rapid growers should also go to routine bacterial and fungal media , because those organisms often appear there first.

Blood for mycobacteria is a dedicated culture. MAC bacteremia in untreated advanced HIV is the scenario the exam loves: fever, wasting, anemia, and AFB from blood or bone marrow. A routine bacterial blood-culture instrument is not validated as an AFB recovery system.

Soft-tissue mycobacteria and Nocardia hide in nodules, ulcers, and surgical sites. Tell the bench the exposure : fish tank, seawater, tattoo, injection, soil-contaminated trauma, or transplant. That history chooses 30 °C incubation and a modified acid-fast stain, not just a 37 °C MGIT.

Mycobacterium tuberculosis: person-to-person droplet nuclei

M. tuberculosis (and the rest of the M. tuberculosis complex) is the only common mycobacterium that spreads person to person . Infectious particles are airborne droplet nuclei (about 1–5 µm) generated by coughing, singing, or aerosol-generating procedures. They remain suspended and reach alveoli. Fomites and casual surface contact are not the usual route. A smear-positive cavitary patient is the classic transmitter; latent TB infection is not contagious.

Clinically the exam splits latent infection (immune control, no symptoms, not infectious) from active pulmonary or extrapulmonary disease . Cavities, night sweats, weight loss, and hemoptysis are the pulmonary picture. Extrapulmonary TB (lymph node, bone, genitourinary tract, meningitis) still starts from a respiratory acquisition in most hosts. Culture manipulation of M. tuberculosis is a BSL-3 activity because a grown culture is a concentrated aerosol risk. Smear preparation from digested sputum is performed in a certified BSC with centrifuge safety cups; never sniff an AFB plate, and never work a mold-like buff colony from mycobacterial medium on the open bench.

MAC/MAI: environmental, AIDS-disseminated

M. avium complex (MAC) , historically called M. avium–intracellulare (MAI), is acquired from water and soil , not from another patient’s cough. Person-to-person spread is not the epidemiology. Two disease states dominate:

Disseminated MAC in advanced AIDS (typically very low CD4 counts), with mycobacteremia, marrow involvement, and gastrointestinal disease.

Chronic pulmonary MAC in older adults with COPD or nodular bronchiectasis, and in cystic fibrosis , without HIV.

MAC is a slow-growing nonphotochromogen. A single respiratory isolate in a patient without compatible disease may be airway colonization or water contamination. Repeated isolation plus radiology and symptoms is what turns MAC into a pulmonary pathogen. Blood isolates in AIDS are not contaminants.

M. kansasii, M. abscessus group, and M. marinum

M. kansasii causes pulmonary disease that looks like TB : upper-lobe cavities, cough, and weight loss. It is a slow-growing photochromogen (pigment after light—details in 14.2). It is associated with municipal water but is treated as a true pathogen when the clinicoradiographic picture fits, not as a tap-water throwaway.

The M. abscessus group is a rapid grower (visible colonies in fewer than 7 days, often on routine bacterial media). It is a major nontuberculous mycobacterium of CF and other chronic lung disease , and it causes skin and soft-tissue infection after surgery, injection, or trauma. Isolation from CF sputum is clinically important because the organism can persist in damaged airways. Do not confuse it with MAC: time-to-colony is the first split.

M. marinum is fish-tank (or swimming-pool) granuloma . Traumatic inoculation in aquarium or seawater produces nodular or sporotrichoid lesions on cool extremities. The laboratory clue is growth at 30 °C with poor or no growth at 37 °C. If the skin specimen is incubated only at 37 °C, the culture can be falsely negative.

Nocardia and the tap-water contaminant

Nocardia spp. are aerobic actinomycetes, not mycobacteria . They appear as branching Gram-positive filaments , often beaded, that are partially acid-fast on a modified acid-fast stain (weak acid decolorizer) and negative or only faintly colored with standard mycobacterial acid-alcohol. Disease is pulmonary nocardiosis that can seed brain abscesses in immunocompromised hosts (transplant, high-dose steroids, chronic granulomatous disease). Traumatic cutaneous nocardiosis occurs in immunocompetent people. Colonies are dry and chalky and may show aerial hyphae on bacterial or fungal media over several days. A “partially AFB-positive filament from lung or brain” is Nocardia until the identification says otherwise.

M. gordonae is the common tap-water scotochromogen . It contaminates sputum cups, ice machines, bronchoscopes, and laboratory water. A single isolate from a patient without disease is not TB and is not MAC. Report it with clinical correlation; do not trigger BSL-3 public-health panic for a yellow-orange water organism.

Safety closes the loop: BSL-3 for TB culture . NTM and Nocardia are generally handled with BSL-2 practices once M. tuberculosis complex is excluded, but any unidentified AFB from a pulmonary specimen is treated as TB until the identification is known. That is why growth rate plus pigment (14.2) and molecular direct detection (14.3) decide containment, not just the final species name.

Loading diagram... Specimen source to major mycobacterial and Nocardia disease states

Preferred incubation temperature (°C) for major AFB and Nocardia workups